Peter Dias

Strong Immunostaining for Myogenin in Rhabdomyosarcoma Is Significantly Associated with Tumors of the Alveolar Subclass

Peter Dias, Bin Chen, Brad Dilday et al. · American Journal Of Pathology · 2000 · 191 citations · Full text

Medicine, Oncology, Pathology +12

Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma.

David N. Shapiro, Bart G. Jones, LH Shapiro et al. · Journal of Clinical Investigation · 1994 · 168 citations · Full text

Medicine, Cancer Biology, Oncology +13

Myogenic regulatory protein (MyoD1) expression in childhood solid tumors: diagnostic utility in rhabdomyosarcoma.

Peter Dias, David M. Parham, David N. Shapiro et al. · PubMed · 1990 · 145 citations

Medicine, Molecular Biology, Oncology +10

Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.

Michael B. Dilling, Peter Dias, David N. Shapiro et al. · PubMed · 1994 · 135 citations

Medicine, Oncology, Pharmacology +17

MyoDl Protein Expression in Alveolar Soft Part Sarcoma As Confirmatory Evidence of Its Skeletal Muscle Nature

Juan Rosaí, Peter Dias, David M. Parham et al. · The American Journal of Surgical Pathology · 1991 · 109 citations

Medicine, Cell Biology, Oncology +13